Your browser doesn't support javascript.
loading
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.
Johnson, Matthew G; Strizki, Julie M; Brown, Michelle L; Wan, Hong; Shamsuddin, Hala H; Ramgopal, Moti; Florescu, Diana F; Delobel, Pierre; Khaertynova, Ilsiyar; Flores, José F; Fouche, Leon F; Chang, Shan-Chwen; Williams-Diaz, Angela; Du, Jiejun; Grobler, Jay A; Paschke, Amanda; De Anda, Carisa.
Afiliación
  • Johnson MG; Merck & Co., Inc., Rahway, NJ, USA. matthew.johnson1@merck.com.
  • Strizki JM; Merck & Co., Inc., Rahway, NJ, USA.
  • Brown ML; Merck & Co., Inc., Rahway, NJ, USA.
  • Wan H; Merck & Co., Inc., Rahway, NJ, USA.
  • Shamsuddin HH; Merck & Co., Inc., Rahway, NJ, USA.
  • Ramgopal M; Midway Immunology and Research Center, Fort Pierce, FL, USA.
  • Florescu DF; University of Nebraska Medical Center, Omaha, NE, USA.
  • Delobel P; Université Toulouse III Paul Sabatier, CHU de Toulouse, Toulouse, France.
  • Khaertynova I; Republican Clinical Infectious Diseases Hospital n.a. A.F. Agafonov, Kazan, Russian Federation.
  • Flores JF; Clinica Privada Dr. José Francisco Flores López, Guatemala, Guatemala.
  • Fouche LF; Limpopo Clinical Research Initiative, Thabazimbi, South Africa.
  • Chang SC; National Taiwan University Hospital, Taipei, Taiwan.
  • Williams-Diaz A; Merck & Co., Inc., Rahway, NJ, USA.
  • Du J; Merck & Co., Inc., Rahway, NJ, USA.
  • Grobler JA; Merck & Co., Inc., Rahway, NJ, USA.
  • Paschke A; Merck & Co., Inc., Rahway, NJ, USA.
  • De Anda C; Merck & Co., Inc., Rahway, NJ, USA.
Infection ; 51(5): 1273-1284, 2023 Oct.
Article en En | MEDLINE | ID: mdl-36648627
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Infection Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Infection Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos